FY2023 · ended Dec 31, 2023 · Revenue $2.16M, -67.8% YoY · Filed Apr 15, 2024
Can B Corp. (NASC) files with the SEC under industry code 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries. In fiscal 2023, which ended Dec 31, 2023, it reported revenue of $2.2 million and a net loss of $9.7 million. Free cash flow was -$1.3 million. As of Sep 30, 2024 it held $7,879 in cash and investments and $254,391 in total debt.
Revenue (TTM)
$1.03M
-57.7% vs year-ago TTM
Net income (TTM)
$-13.26M
-22.4% vs year-ago TTM
Operating cash flow (TTM)
$246,464
+112.4% vs year-ago TTM
Free cash flow
$-1.32M
+83.5% vs prior year
EPS (TTM)
$-0.29
Dividend per share
None
Shares outstanding
49.34M
+814.3% vs prior year
Net cash
$-246,512
as of Sep 30, 2024
Operating margin
-1035.9%
FY 2024
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- NASC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Hicksville, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1509957
- Former names
- Canbiola, Inc. (until Mar 3, 2020); Wrapmail, Inc. (until May 15, 2017)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
FY 2020 Dec 31, 2020 |
FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| Revenue | $2.2M | $6.7M | $4.6M | $1.7M | $2.3M |
| Operating income | -$7.5M | -$14.2M | -$10.3M | -$7.5M | -$5.9M |
| Net income | -$9.7M | -$14.9M | -$12.2M | -$8.9M | -$5.9M |
| Diluted EPS | -$0.77 | — | — | -$1.36 | — |
| Operating cash flow | -$1.3M | -$3.9M | -$7.5M | -$1.9M | -$2.4M |
| Free cash flow | -$1.3M | — | -$8.0M | -$2.0M | -$3.5M |
| Total assets | $10.1M | $15.6M | $16.5M | $3.9M | $7.2M |
| Total liabilities | $11.1M | $12.9M | $10.9M | $2.4M | $564,666 |
| Stockholders' equity | -$1.0M | $2.7M | $5.6M | $1.5M | $6.6M |
| Cash and investments | $34,006 | $73,194 | $449,001 | $457,798 | $46,540 |
| Total debt | $254,391 | $1.1M | $2.2M | $43,506 | $97,279 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 19, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Material agreement, Listing notice, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change
|
Oct 28, 2024 | Oct 25, 2024 |
| 10-Q | Quarterly report | Aug 19, 2024 | Jun 30, 2024 |
| 10-Q/A | Amended quarterly report | Jul 17, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Exit or restructuring costs
|
Jun 18, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Auditor change
|
May 31, 2024 | May 24, 2024 |
All 280 Can B Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.